The Patent Finder

Tracon Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Tracon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Tracon Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,944,714Endoglin antibodies
Formerly held
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 9,150,652Endoglin antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,221,753Endoglin antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,195,281Antibody formulations and uses thereof
Formerly held
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 8,017,618Antifolate agent combinations in the treatment of cancer
Lapsed on the fee record
Ended Sep 13, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 13, 2023From the USPTO record
US 10,336,831Use of anti-endoglin antibodies for treating ocular fibrosis
Formerly held
Lapsed on the fee record
Ended Jul 2, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 2, 2023From the USPTO record
US 10,155,820Anti-endoglin antibodies and uses thereof
Formerly held
Lapsed on the fee record
Ended Dec 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 18, 2022From the USPTO record
US 9,926,375Anti-endoglin antibodies and uses thereof
Formerly held
Lapsed on the fee record
Ended Mar 27, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2022From the USPTO record
US 8,609,094Endoglin antibodies
Formerly held
Lapsed on the fee record
Ended Dec 17, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 17, 2021From the USPTO record
US 9,518,122Endoglin antibodies
Formerly held
Lapsed on the fee record
Ended Dec 13, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited